Uplizna
Chemical Name | inebilizumab-cdon |
Dosage Form | Injection (intravenous; 100 mg/10 mL) |
Drug Class | Monoclonal antibodies |
System | Nervous |
Company | Viela Bio |
Approval Year | 2020 |
Indication
- Indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.